HALO - Halozyme Therapeutics Inc.
IEX Last Trade
63.82
0.080 0.125%
Share volume: 959,677
Last Updated: Fri 30 Aug 2024 09:59:53 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$63.74
0.08
0.13%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-09 | 2022-11-08 | 2023-02-21 | 2023-05-09 | 2023-08-08 | 2023-11-06 | 2024-02-20 | 2024-05-07 | |
| Total revenue | 152.365 M | 208.976 M | 181.496 M | 162.143 M | 221.038 M | 216.033 M | 230.039 M | 195.879 M | |
| Cost of revenue | 33.943 M | 47.319 M | 42.120 M | 35.170 M | 50.070 M | 54.823 M | 52.298 M | 28.329 M | |
| Gross profit | 118.422 M | 161.657 M | 139.376 M | 126.973 M | 170.968 M | 161.210 M | 177.741 M | 167.550 M | |
| 36.51% | -13.78% | -8.90% | 34.65% | -5.71% | 10.25% | -5.73% | |||
| Operating expenses | 72.959 M | 51.172 M | 60.315 M | 55.336 M | 58.675 M | 52.590 M | 58.944 M | 54.245 M | |
| Selling general and admin | 57.476 M | 34.467 M | 37.749 M | 37.357 M | 38.948 M | 35.269 M | 37.608 M | 35.134 M | |
| Research and development | 15.483 M | 16.705 M | 22.566 M | 17.979 M | 19.727 M | 17.321 M | 21.336 M | 19.111 M | |
| Total expenses | 118.305 M | 125.684 M | 106.987 M | 108.341 M | 126.580 M | 127.754 M | 129.004 M | 100.337 M | |
| 6.24% | -14.88% | 1.27% | 16.83% | 0.93% | 0.98% | -22.22% | |||
| Operating income | 34.060 M | 83.292 M | 74.509 M | 53.802 M | 94.458 M | 88.279 M | 101.035 M | 95.542 M | |
| Ebit | 34.060 M | 83.292 M | 74.509 M | 53.802 M | 94.458 M | 88.279 M | 101.035 M | 95.542 M | |
| Pretax income | 30.011 M | 73.707 M | 70.791 M | 52.238 M | 93.156 M | 101.760 M | 101.175 M | 96.028 M | |
| 145.60% | -3.96% | -26.21% | 78.33% | 9.24% | -0.57% | -5.09% | |||
| Income tax | 7.326 M | 12.073 M | 13.089 M | 12.623 M | 18.402 M | 19.923 M | 15.787 M | 19.205 M | |
| Net income basic | 22.685 M | 61.634 M | 57.702 M | 39.615 M | 74.754 M | 81.837 M | 85.388 M | 76.823 M | |
| 171.69% | -6.38% | -31.35% | 88.70% | 9.48% | 4.34% | -10.03% | |||
| Net income | 22.685 M | 61.634 M | 57.702 M | 39.615 M | 74.754 M | 81.837 M | 85.388 M | 76.823 M | |
| 171.69% | -6.38% | -31.35% | 88.70% | 9.48% | 4.34% | -10.03% |